SIBN - Si-Bone - Stock Price & Dividends

SI-BONE, Inc. is a medical device company that specializes in developing innovative solutions to address musculoskeletal disorders affecting the sacropelvic anatomy, a complex region that includes the sacrum, pelvis, and surrounding joints.

The company's flagship product is a proprietary, minimally invasive surgical implant system designed to treat a range of conditions, including sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma. This system offers a less invasive alternative to traditional surgical methods, reducing recovery time and promoting faster healing.

SI-BONE's product portfolio includes the iFuse-3D, a titanium implant that combines a triangular cross-section with a proprietary 3D-printed porous surface and fenestrated design. This implant is designed to provide optimal stability and promote bone growth. The company also offers iFuse-TORQ, a set of 3D-printed threaded implants specifically designed to treat pelvic trauma, and the iFuse Bedrock Granite implant, which provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion.

In terms of sales and marketing, SI-BONE relies on a direct sales force, as well as partnerships with agents and resellers, to promote its products to healthcare professionals and medical institutions. With a strong online presence, the company provides educational resources and support to help clinicians and patients better understand its innovative solutions.

Founded in 2008, SI-BONE is headquartered in Santa Clara, California, and has established itself as a leader in the medical device industry, committed to improving patient outcomes and advancing the field of musculoskeletal medicine.